knowledge -WSS

knowledge

author：hotspot 2025-09-28 23:49:01 - browse：84252

Adobe

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing hundreds of millions of dollars in bonuses from the government, a judge ruled Monday.

The decision will lead to more than $250 million funneling back into SCAN, which covers 270,000 Medicare Advantage enrollees. And it opens the door for other Medicare Advantage plans to potentially recoup huge sums of taxpayer-funded bonuses — even though many independent experts believe the quality rating system is flawed and doesn’t appropriately gauge quality of care for older adults and people with disabilities.

The Centers for Medicare and Medicaid Services, the federal agency that oversees all Medicare programs, said it does not comment on litigation. In an interview, SCAN CEO Sachin Jain told STAT that if the company had not gotten its expected bonus money, it would have had to shave benefits and reduce what it pays hospitals and doctors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Wikipedia

WSS

Why a market frenzy over new weight loss drugs defies logic

Explaining an after

How AI can help patients find reliable information about doctors

CZI to create biohub to build anti

Kidney transplant patients stopped immunosuppressants in trial

Is there really a nursing shortage in the U.S.?

knowledge

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Study on Amgen’s bispecific immunotherapy produces positive data

Dobbs anniversary: the lost opportunity of abortion as health care

How to convince healthy people to buy insurance

Virginia high school admissions case could be legal follow

Bill would allow buprenorphine prescription for addiction via telehealth

Medical records are filled with copy

What is microchimerism and how does it affect maternal health?

Dobbs anniversary: the lost opportunity of abortion as health care

Medicare proceeds with plan to claw back hospital funds

Wikipedia

Humans aren't the only ones with an imagination. Rats have it too

Roche drug slashes death risk in early

Is there really a nursing shortage in the U.S.?

After Sarepta trial failure, Duchenne families brace for more debate

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

J&J lung cancer data amount to new salvo against AstraZeneca

focus

hotspot

Wikipedia

entertainment